Patient Information Booklet for Patients Switching from Warfarin to Apixaban for Stroke Prevention in NVAF
Eliquis is indicated for Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors such as prior stroke or transient ischaemic (TIA), age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (New York Heart Association
This booklet is intended only for patients prescribed ELIQUIS for the indication shown. It is not intended to replace the Patient Information Leaflet.
This booklet is intended to be read by patients only after they have been prescribed ELIQUIS. It may be read in its electronic format (PDF) or it may be printed and read.
Switching from warfarin to ELIQUIS should be done under close clinical supervision. Any prescribing decision should only be made by the prescribing healthcare professional on the basis of sound clinical reasons and after appropriate assessment with patient involvement in the
decision-making.
If a Patient Information Booklet is printed, please ensure that:
- It is printed in its entirety. Please do not attempt to print and use individual pages in isolation, as it has been designed to be printed in its entirety
- Its content is not edited or altered in any way
- It is in colour
- It is printed in A4 size
- The pages are placed in the correct order as per the page numbering
Please select the language of the Patient Information Booklet you would like to view below:
This booklet is also available to patients prescribed ELIQUIS via the patient section of the website.